Double Strength Zymactive
On sale on the US market (according to the DSLD)
Natural Factors, food supplement from the US market
Double Strength Zymactive (Natural Factors), a food supplement au code-barres 068958017525, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Natural Factors
- Barcode
- 068958017525
- Form
- Tablet
- One serving
- 2 tablets
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Microcrystalline Cellulose, Aqueous Coating solution, Croscarmellose Sodium, Magnesium Stearate
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Enzyme Blend | Blend | 510 mg |
| Pancreatic Enzymes 11x | Blend | 292 mg |
| Amylase, Pancreatic | Enzyme | not stated |
| Protease, Pancreatic | Enzyme | not stated |
| Lipase, Pancreatic | Enzyme | not stated |
| Papain | Enzyme | 171.44 mg |
| Serratia Peptidase | Enzyme | 9.44 mg |
| Bromelain | Enzyme | 38.8 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Double Strength Zymactive
Entered into DSLD on 21 September 2018. Withdrawn from the US market on 7 April 2020 (according to the DSLD).Same active composition.
Official label: Double Strength Zymactive
Entered into DSLD on 23 June 2017. Withdrawn from the US market on 2 February 2018 (according to the DSLD).- Active ingredient added : Pancreatin 8X (400 mg)
- Active ingredient added : Serratiopeptidase (104 mg)
- Active ingredient removed : Amylase, Pancreatic (quantity not stated)
- Active ingredient removed : Enzyme Blend (510 mg)
- Active ingredient removed : Lipase, Pancreatic (quantity not stated)
- Active ingredient removed : Pancreatic Enzymes 11x (292 mg)
- Active ingredient removed : Protease, Pancreatic (quantity not stated)
- Active ingredient removed : Serratia Peptidase (9.44 mg)
- Different quantity per serving : Bromelain: 100 mg in this version; 38.8 mg on the displayed label
- Different quantity per serving : Papain: 240 mg in this version; 171.44 mg on the displayed label
Official label: Double Strength Zymactive Proteolytic Enzymes
Entered into DSLD on 1 June 2012. Withdrawn from the US market on 6 May 2017 (according to the DSLD).- Active ingredient added : Pancreatin 8X (400 mg)
- Active ingredient added : Serratiopeptidase (104 mg)
- Active ingredient removed : Amylase, Pancreatic (quantity not stated)
- Active ingredient removed : Enzyme Blend (510 mg)
- Active ingredient removed : Lipase, Pancreatic (quantity not stated)
- Active ingredient removed : Pancreatic Enzymes 11x (292 mg)
- Active ingredient removed : Protease, Pancreatic (quantity not stated)
- Active ingredient removed : Serratia Peptidase (9.44 mg)
- Different quantity per serving : Bromelain: 100 mg in this version; 38.8 mg on the displayed label
- Different quantity per serving : Papain: 240 mg in this version; 171.44 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Serratia Peptidase
Read the warning, when it applies and the studies cited
SERRAPEPTASE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gastrointestinal lesions/ulcers, a kidney or liver disorder, or are having surgery (Bhagat et al. 2013; Chopra et al. 2009; Al- Khateeb and Nusair 2008; Mazzone et al. 1990).
Sources cited by Health Canada (4)
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
- Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomised trial
- Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomised trial
- Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomised trial
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or anti-inflammatory medications (Bhagat et al. 2013; Chopra et al. 2009; Al-Khateeb and Nusair 2008; Mazzone et al. 1990).
Sources cited by Health Canada (4)
- Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomised trial
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
- Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomised trial
- Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomised trial
Known adverse reactions
Stop use if rash, difficulty breathing, hypersensitivity and/or severe allergy occur (Bhagat et al. 2013; Balagi 2007).
Sources cited by Health Canada (1)
- Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematic review
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Natural Factors
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Double Strength Zymactive (Natural Factors): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/68958017525-double-strength-zymactive-natural-factors, updated 24 June 2020.